 has been appointed Chief Financial Officer of 

, MD, has been named Vice President and Global Head, Medical Affairs, at 

(Cincinnati, OH) where he will provide global leadership for the company's medical affairs organization. 

has been appointed as Senior Director and Global Head, Patient Recruitment.  

to fill its newly-created position of Director of Patient Recruitment.   

(Raleigh, NC)  has made four additions to its team including 

as Vice President and Chief Business Development Officer, 

 as Regional Directors of Business Development, and

 as Manager of Quality Assurance and Regulatory Compliance.   

, MD, as Senior Vice President of Global Regulatory Affairs. 

 will strengthen the company's proprietary HD360° technology platform. 

• Previously the Senior Therapeutic Director for Oncology at i3, 

 (Research Triangle Park, NC) as Vice President, Clinical Operations. 

, PhD, as Patient Reported Outcomes Scientific Advisor where she will lead CRF Health's PRO consulting initiative providing scientific insight and guidance to clients and internal staff, as well as to the global clinical trial sector.   

(Princeton, NJ) oncology team in his new role as Vice President, Clinical Research.  

Concord, OH) Analytical Chemistry department. 

• Leading sales, marketing, and business development strategies for late stage business, 

 will use her previous drug development experience as  

(King of Prussia, PA)  Executive Vice President, Global Business Development.  

 to the position of Director of Contracts and Budgets where she will supervise a team of contract specialists in the St. Louis and Brussels offices, and 

has been hired to the position of Business Development Director, Europe. 

(Manchester, UK) has made several changes to its executive management team with the appointment of 

• Bringing with her more than 20 years experience, 

, PhD, has been appointed Global Regulatory and Clinical Affairs Manager by 

CTI Clinical Trial and Consulting Services

has joined as Director, Business Development Operations. 

 (Redmond, WA) have entered into an agreement to jointly implement a technology solution designed to improve efficiency in managing Risk Evaluation and Mitigation Strategy programs by using Microsoft Amalga Unified Intelligence System and Microsoft HealthVault.

 (Newtown, PA) has created strategic partnerships with 

(Flemington, NJ) to strengthen the BioClinica Certified Partner Program and provide customers with additional support in therapeutic areas of study and data monitoring and management.

(Califon, NJ) has signed a master services agreement with 

 (Dresden, Germany) to begin clinical studies and regulatory filings for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's Disease.  

(Toronto, Canada) has created a global collaboration with LabCorp through its 

(Cranford, NJ) division, providing clients with access to CAP-accredited laboratories across both. Under the agreement, clients of each company will be able to access LabCorp's  assay portfolio and Clearstone's central laboratory protocol management system: APOLLO CLPM.

 (Surrey, UK) have entered into a strategic partnership giving Argint exclusive distribution rights for the Academy's training courses throughout Central and South Eastern Europe.

(Buckinghamshire, UK) has entered into a collaboration with the 

 (PACRA) (Singapore), which allows ICR to expand its global presence in the Asia Pacific region by letting the company provide research and training to PACRA members research professionals across the region. As part of the agreement, the ICR's members' journal CRfocus will be produced quarterly and rebranded as "Silk Route" for the Asia Pacific members via the PACRA website.

(San Ramon, CA) have been named to the Inc. 5000 list, a listing compiled annually by Inc. Magazine, recognizing America's fastest-growing private companies, for the fourth year in a row. 

(Chapel Hill, NC) has been designated as one of the 50 most family-friendly places to work in North Carolina for 2010 by Carolina Parent Magazine.

 (Wilminton,  NC) has established preferred provider relationships with a network of sites including Commonwealth Biomedical Research (Madisonville, KY), 

 (Albuquerque, NM), in order to conduct Phase I trials to meet growing client demand for these services.

(Chicago, IL), has formed to provide study visits in the home or other alternate site settings through a network of clinicians.

 (Plymouth Meeting, PA) has launched an Inventory Management Program that offers device buyback options, third-party brokerage services to transfer devices between clients, new equipment for long-term investment, reconditioned equipment to reduce the upfront costs, refurbishing services on both client owned devices and newly acquired devices, and leasing options. The company has also recently completed the ePRO vendor certification program for use with the EXAcerbations of Chronic Pulmonary Disease Tool, a patient-reported outcome measure designed to standardize the method for evaluating the frequency, severity, and duration of acute exacerbations of chronic obstructive pulmonary disease and chronic bronchitis in the United States, as well as international based studies and clinical trials.  

(Derby,  UK) has been appointed by a Japanese pharmaceutical company to handle the clinical trial drug manufacture of two NCEs for UK trials, which marks the first time the Japenese company has outsourced clinical trials manufacture to a European company.  

(Woodlands, TX) has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration, assisting most recently with Tasigna capsules, a medicine developed by Novartis.

To expand its biopharmaceutical development services globally, the 

(Boston, MA) have made a series of acquisitions including 

(Bethesda, MD) for approximately $730 million. 

(Redwood Shores, CA) has completed its acquisition of 

News

Applied Clinical Trials-10-01-2010

Industry news focusing on the people and organizations who work in the clinical trials profession.